Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment

Bibliographic Details
Main Authors: M. Vassallo, J. Durant, R. Fabre, F. DeSalvador, C. Lebrun-Frenay, M. Laffon, M. Ticchioni, J. Cottalorda, P. Dellamonica, C. Pradier
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020313881
_version_ 1819049376616546304
author M. Vassallo
J. Durant
R. Fabre
F. DeSalvador
C. Lebrun-Frenay
M. Laffon
M. Ticchioni
J. Cottalorda
P. Dellamonica
C. Pradier
author_facet M. Vassallo
J. Durant
R. Fabre
F. DeSalvador
C. Lebrun-Frenay
M. Laffon
M. Ticchioni
J. Cottalorda
P. Dellamonica
C. Pradier
author_sort M. Vassallo
collection DOAJ
first_indexed 2024-12-21T11:31:10Z
format Article
id doaj.art-b3a1a80c969f4ecc98e50248d7b4d8fc
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-12-21T11:31:10Z
publishDate 2015-12-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-b3a1a80c969f4ecc98e50248d7b4d8fc2022-12-21T19:05:33ZengElsevierJournal of Virus Eradication2055-66402015-12-0113233Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairmentM. Vassallo0J. Durant1R. Fabre2F. DeSalvador3C. Lebrun-Frenay4M. Laffon5M. Ticchioni6J. Cottalorda7P. Dellamonica8C. Pradier9Cannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, FranceCannes General Hospital, Cannes, Francehttp://www.sciencedirect.com/science/article/pii/S2055664020313881
spellingShingle M. Vassallo
J. Durant
R. Fabre
F. DeSalvador
C. Lebrun-Frenay
M. Laffon
M. Ticchioni
J. Cottalorda
P. Dellamonica
C. Pradier
Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
Journal of Virus Eradication
title Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
title_full Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
title_fullStr Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
title_full_unstemmed Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
title_short Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment
title_sort immune activation in successfully treated patients with hiv associated neurocognitive disorders difference according to the severity of the impairment
url http://www.sciencedirect.com/science/article/pii/S2055664020313881
work_keys_str_mv AT mvassallo immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT jdurant immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT rfabre immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT fdesalvador immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT clebrunfrenay immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT mlaffon immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT mticchioni immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT jcottalorda immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT pdellamonica immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment
AT cpradier immuneactivationinsuccessfullytreatedpatientswithhivassociatedneurocognitivedisordersdifferenceaccordingtotheseverityoftheimpairment